TrialBMJ (Clinical research ed.)2015

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

David Pace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.